AI assistant
Sending…
Lyra Therapeutics, Inc. — Director's Dealing 2020
Oct 30, 2020
35183_dirs_2020-10-29_cc5a3475-4974-4885-a448-7529ffb0ed8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Lyra Therapeutics, Inc. (LYRA)
CIK: 0001327273
Period of Report: 2020-10-27
Reporting Person: snyderman nancy lynn MD (Director)
More from Lyra Therapeutics, Inc.
Delisting Announcement
2026
Apr 20
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 10
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 27
Regulatory Filings
2026
Feb 6
Major Shareholding Notification
2026
Jan 20